Table 1.
Demographic and clinical data for OCD patients and healthy controls
|
Variables |
Pre-treatment groups (case) |
|
Treatment remission groups (case) |
|
||
|---|---|---|---|---|---|---|
| OCD group (19) | Controls (30) | P | SSRI (11) | SSRI/quetiapine (8) | P | |
| sex (female, %) |
9(47) |
13(43) |
0.214 |
5(45) |
4(50) |
0.305 |
| age (years) |
27.21 ± 8.75 |
29.25 ± 6.81 |
0.291 |
28.18 ± 8.2 |
26.78 ± 7.66 |
0.286 |
| education (years) |
12.66 ± 3.17 |
13.30 ± 2.47 |
0.667 |
12.12 ± 3.77 |
12.53 ± 3.13 |
0.797 |
| length of illness (years) |
2.47 ± 1.33 |
|
— |
2.33 ± 1.99 |
2.97 ± 1.34 |
0.714 |
| pre-treatment scales | ||||||
| Y-BOCS total score |
24.55 ± 6.72 |
11.12 ± 5.12 |
0.013 |
24.36 ± 6.22 |
24.55 ± 7.41 |
0.731 |
| HAMD total score |
21.21 ± 4.36 |
16.33 ± 2.41 |
0.044 |
21.30 ± 4.11 |
21.00 ± 4.17 |
0.712 |
| Post-treatment scales | ||||||
| Y-BOCS total score |
12.48 ± 5.20 * |
|
— |
11.51 ± 5.01 * |
11.36 ± 5.14 * |
0.512 |
| HAMD total score | 17.31 ± 3.49 * | — | 17.03 ± 3.18 * | 17.21 ± 3.33 * | 0.647 | |
*p < 0.01, compared to the pre-treatment score.